Electromyographic (EMG) Biofeedback Training in Zone I-III Flexor Tendon Injuries
The Effect of Electromyographic (EMG) Biofeedback Training on Electrical Muscle Activity and Functional Status in Zone I-III Flexor Tendon Injuries
1 other identifier
interventional
22
0 countries
N/A
Brief Summary
Aim: The aim of the study was to investigate the effect of electromyographic (EMG) biofeedback training applied in addition to early passive motion protocol on electrical muscle activity (EMA) and functional status in zone I-III flexor tendon injuries. Materials and Methods: Cases who underwent surgery for flexor tendon injuries in zone I-III were included in this prospective randomized controlled trial. Cases were randomly divided into two groups of 11 cases each by block randomization. In the first group, EMG biofeedback training was applied in addition to the early passive motion method (modified Duran protocol), while the second group was followed only by early passive motion method. The treatment program was performed by the same physiotherapist three times a week, for 12 weeks. At the postoperative 5th, 12th and 24th weeks, joint range of motion (ROM) and EMA were evaluated, and the Michigan Hand Outcome Questionnaire (MHQ) was administered to the patients. The grip strength at 12th and 24th weeks were also assessed. The Mann-Whitney U Test was used to compare the two groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2016
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 10, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 10, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 21, 2019
CompletedFirst Submitted
Initial submission to the registry
January 15, 2020
CompletedFirst Posted
Study publicly available on registry
January 23, 2020
CompletedJanuary 27, 2020
January 1, 2020
2.2 years
January 15, 2020
January 23, 2020
Conditions
Outcome Measures
Primary Outcomes (11)
Finger joint range of motion
Finger motion was measured by goniometer.Total active motion protocol was used.
5th week
Finger joint range of motion
Finger motion was measured by goniometer.Total active motion protocol was used.
12th week
Finger joint range of motion
Finger motion was measured by goniometer.Total active motion protocol was used.
24th week
Electrical muscle activity
Flexor muscle electrical activity was measured by EMG biofeedback device. For this purpose, surface electrodes were used.
5th week
Electrical muscle activity
Flexor muscle electrical activity was measured by EMG biofeedback device. For this purpose, surface electrodes were used.
12th week
Electrical muscle activity
Flexor muscle electrical activity was measured by EMG biofeedback device. For this purpose, surface electrodes were used.
24th week
Grip strength
Gross and pinch strength were evaluated by hand dynamometer.
12th week
Grip strength
Gross and pinch strength were evaluated by hand dynamometer.
24th week
Michigan Hand Questionnaire
This questionnaire evaluates the functionality of the hand and consists of 63 questions in total. Each question is scored between 1-5 and the score of each section varies between 0-100. High total score indicates high satisfaction.
5th week
Michigan Hand Questionnaire
This questionnaire evaluates the functionality of the hand and consists of 63 questions in total. Each question is scored between 1-5 and the score of each section varies between 0-100. High total score indicates high satisfaction.
12th week
Michigan Hand Questionnaire
This questionnaire evaluates the functionality of the hand and consists of 63 questions in total. Each question is scored between 1-5 and the score of each section varies between 0-100. High total score indicates high satisfaction.
24th week
Study Arms (2)
EMG biofeedback group
EXPERIMENTALcontrol group
NO INTERVENTIONInterventions
Eligibility Criteria
You may qualify if:
- Being olunteer,
- No history of neurological, orthopedic, rheumatologic disease or trauma in the related extremity,
- No history of neuropathy due to a metabolic disease (diabetes, etc.),
- Incision of at least one of the FDS or FDP tendons,
- At least one of the FDS or FDP tendons repaired within 2 weeks after the injury,
- No communication problems.
You may not qualify if:
- \<18 years of age,
- Pregnancy,
- Thumb flexor tendon cuts,
- Digital nerve injury,
- Accompanying fracture, joint capsule injury or skin loss,
- Crush injury,
- Patients with pacemakers,
- Patients with cardiac arrhythmias,
- Epilepsy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- STUDY DIRECTOR
Ali Kitis, PhD
Pamukkale University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
January 15, 2020
First Posted
January 23, 2020
Study Start
October 10, 2016
Primary Completion
December 10, 2018
Study Completion
March 21, 2019
Last Updated
January 27, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share